Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1475 of 5804
-
New study aims to reduce leg swelling in endometrial cancer surgery
Symptom relief Recruiting nowThis phase III trial compares the effect of sentinel lymph node mapping to standard lymph node dissection in reducing the risk of swelling in the legs (lymphedema) in patients undergoing a hysterectomy for stage I endometrial cancer. Standard lymph node dissection removes lymph n…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New pill targets joylessness in depression – phase 3 trial complete
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy of aticaprant compared with placebo as adjunctive therapy to an antidepressant in improving depressive symptoms in adult participants with major depressive disorder (MDD) with moderate to severe anhedonia (ANH+) who have had a…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Spinal pump may ease cancer pain when pills fail
Symptom relief CompletedThis Registry study will prospectively evaluate the differences in treatment outcomes in terms of pain intensity, pain interference, concomitant medication use, health-related quality of life, opioid adverse effects, and healthcare utilization between targeted drug delivery and c…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New combo therapy shows promise for Tough-to-Treat lymphoma
Disease control CompletedThe purpose of this study is to provide continued access to treatment for participants who continue to benefit from treatment.
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Experimental drug aims to help ARDS patients breathe easier
Disease control CompletedStudy objectives 1. To characterize the efficacy of reparixin in ameliorating lung injury and systemic inflammation and expediting clinical recovery and liberation from mechanical ventilation in adult patients with moderate to severe ARDS (PaO2/FIO2 ratio ≤ 200). 2. to assess th…
Phase: PHASE2 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Snoring kids may skip surgery: nasal spray trial shows promise
Symptom relief CompletedMIST+ is studying a nasal spray to see if it will reduce the need for surgery for snoring. Children aged 3-12 are invited to take part. Snoring affects up to 10% of children and can cause sleeping problems and concentration or behavioural issues in the daytime. Currently the most…
Phase: PHASE4 • Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New drug combo tested for tough cancers
Disease control OngoingCancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess safety, tolerability, pharmacokinetics and preliminary efficacy of ABBV-706 as a monotherapy and in combination with budigalimab, carboplatin, or…
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can an arthritis drug tame brain inflammation in Alzheimer's and ALS?
Disease control CompletedThis is an open-label, biomarker-driven basket trial of baricitinib in people with subjective cognitive disorder, mild cognitive impairment, Alzheimer's disease (AD), Amyotrophic lateral sclerosis (ALS), or asymptomatic carriers of an ALS-related gene, such as a hexanucleotide ex…
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Early pregnancy iron levels may flag diabetes risk
Diagnosis CompletedThis prospective study evaluates a target population of pregnant women at the time of pregnancy diagnosis to investigate the predictive value of serum ferritin (SF) levels for the later development of gestational diabetes mellitus (GDM). The intervention involves measuring early-…
Sponsor: Zagazig University • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
Battle of the balloons: super High-Pressure vs shockwaves for Rock-Hard arteries
Disease control CompletedThe ISAR-CALC 2 trial is an investigator-initiated, prospective, randomized, multicenter, assessors-blind, open-label other clinical investigation. The objective of this trial is to investigate final angiographic minimal lumen diameter (MLD) following a strategy of super high-pre…
Phase: NA • Sponsor: Deutsches Herzzentrum Muenchen • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Experimental CAR-T therapy takes on Hard-to-Treat lupus nephritis
Disease control OngoingA Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Subjects With Refractory Lupus Nephritis
Phase: PHASE1, PHASE2 • Sponsor: Kyverna Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New injection hopes to heal scarred vocal cords and restore voice
Symptom relief OngoingThe purpose of this study is to confirm the efficacy and safety of KP-100LI, a intracordal formulation containing recombinant human dHGF as the active pharmaceutical ingredient, for voice function improvement therapy in patients with vocal fold scar (including vocal fold sulcus).
Phase: PHASE3 • Sponsor: Kringle Pharma, Inc. • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New drug targets stubborn tremors in Parkinson's
Symptom relief CompletedThis is a 17-week double-blind, placebo-controlled, randomized, flexible-dosing, parallel-group, multicenter study designed to evaluate the efficacy and safety of suvecaltamide for the treatment of moderate to severe residual tremor in adult participants with Parkinson's disease …
Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Could magnetic pulses lift depression in schizophrenia?
Symptom relief Recruiting nowAround 40% of schizophrenia patients present depressive symptoms, which are associated with elevated suicide and violence risk and poor prognosis and quality of life. Recent meta-analysis showed the effect size of antidepressants for depressive symptoms of schizophrenia patients …
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Glowing dye and 3D maps help surgeons remove lung cancer with less damage
Symptom relief Recruiting nowWith the advent of CT screening for lung cancer, an increasing number of NSCLCs are being detected at very early stages, and the demand for pulmonary segmentectomy is rising rapidly. As such, there is a need to develop new surgical techniques to facilitate minimally invasive pulm…
Phase: PHASE1, PHASE2 • Sponsor: St. Joseph's Healthcare Hamilton • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Text messages empower HIV-positive women to take control of family planning
Disease control OngoingUse of a mobile health (mHealth) intervention to provide reproductive life counseling to women living with HIV may improve delivery of integrated reproductive health/HIV services and prevent adverse reproductive health outcomes. The proposed study will evaluate SMS platform and r…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Shock and awe: new combo therapy sparks hope for paraplegia recovery
Disease control CompletedTraumatic Spinal Cord Injury (TSCI) is a catastrophic, unexpected, and devastating event that can occur along the spinal column (cervical, thoracic, and lumbar). Traditional views describe the spinal cord as a protected bundle of nerves connecting the brain to the body. TSCI ofte…
Phase: NA • Sponsor: Lebanese University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can online therapy help depressed moms in head start? large trial launches
Symptom relief Recruiting nowLow income women of childbearing age are at increased risk for depression and often do not receive needed treatment. Investigators developed Mom-Net, an on-line cognitive behavioral treatment (CBT) for depression to address the needs of low income women of childbearing age. The i…
Phase: NA • Sponsor: Oregon Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Three-Drug immune cocktail takes on pancreatic cancer
Disease control TerminatedThis study is being done to test the safety and effectiveness of combining domvanalimab (AB154), zimberelimab (AB122), and APX005M with pancreatic cancer that has spread to other parts of body. This research study involves immunotherapy. Immunotherapy triggers the body's immune …
Phase: PHASE1, PHASE2 • Sponsor: James Cleary, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Ultrasound opens brain barrier to deliver Parkinson's drug in first human test
Disease control Recruiting nowThe goal of this study is to establish safety and feasibility of intracerebral delivery of GCase via MRgFUS. This technique may offer potential benefits given the exposure of the putamen to GCase in animal models has been shown to be efficacious in improving Parkinson's disease p…
Phase: NA • Sponsor: InSightec • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC